Search

Issue
Title
Authors
Therapeutic Strategies to Target Multiple Kinases in Glioblastoma
Sathornsumetee S.
BRAF as a Target for Cancer Therapy
Dienstmann R., Tabernero J.
Capivasertib: First Approved AKT inhibitor for the Treatment of Patients with Breast Cancer
De S.
Targeted Therapies in Metastatic Melanoma: Toward a Clinical Breakthrough?
Julia F., Thomas L., Dumontet C., Dalle S.
Design, Synthesis and Biological Evaluation of Quinoxalin-2(1H)-one Derivatives as EGFR Tyrosine Kinase Inhibitors
Qin X., Han X., Hu L., Li Z., Geng Z., Wang Z., Zeng C., Xiao X.
Cytotoxicity and Cell Death Mechanisms Induced by a Novel Bisnaphthalimidopropyl Derivative against the NCI-H460 non-small Lung Cancer Cell Line
T. Lima R., A. Barron G., A. Grabowska J., Bermano G., Kaur S., Roy N., Helena Vasconcelos M., K.T. Lin P.
Novel Strategies for Hepatocellular Carcinoma Based on MMPs Science
Okazaki I., Inagaki Y.
Mouse Induced Glioma-Initiating Cell Models and Therapeutic Targets
Kondo T.
Focal Adhesion Kinase as a Cancer Therapy Target
M. Golubovskaya V.
The Microarray Gene Profiling Analysis of Glioblastoma Cancer Cells Reveals Genes Affected by FAK Inhibitor Y15 and Combination of Y15 and Temozolomide
Huang G., Ho B., Conroy J., Liu S., Qiang H., Golubovskaya V.
A Steroidal Na+/K+ ATPase Inhibitor Triggers Pro-apoptotic Signaling and Induces Apoptosis in Prostate and Lung Tumor Cells
Honisch S., Alkahtani S., Kounenidakis M., Liu G., Alarifi S., Al-Yahya H., Dimas K., AlKahtane A., Prousis K., Al-Dahmash B., Calogeropoulou T., Alevizopoulos K., Lang F., Stournaras C.
The Therapeutical Potential of a Novel Pterocarpanquinone LQB-118 to Target Inhibitor of Apoptosis Proteins in Acute Myeloid Leukemia Cells
R. de Souza Reis F., C. Casal de Faria F., P. Castro C., S. de Souza P., da Cunha Vasconcelos F., D. Bello R., J. da Silva A., R.R. Costa P., C. Maia R.
Modulation of MMPs by Cell Surface Integrin Receptor α5β1
Pal S., Kumar Ganguly K., Moulik S., Chatterjee A.
Nitroimidazoles as Anti-Tumor Agents
Liu K., Zhu H.
Exploiting Cyclooxygenase-(in)Dependent Properties of COX-2 Inhibitors for Malignant Glioma Therapy
H. Schonthal A.
Hepatocyte Growth Factor Activation Inhibitors – Therapeutic Potential in Cancer
Parr C., Sanders A., Jiang W.
Synthesis and Molecular Dynamic Simulation of Novel Cationic and Non-cationic Pyrimidine Derivatives as Potential G-quadruplex-ligands
Atapour-Mashhad H., Soukhtanloo M., Golmohammadzadeh S., Chamani J., Nejabat M., Hadizadeh F.
Hypersensitivity to Aurora Kinase Inhibitors in Cells Resistant against Platinum- Containing Anticancer Agents
Akiyama M., Izumi H., Wang K., Yamaguchi T., Kuma A., Kitamura N., Harada Y., Oya R., Yamaguchi K., Iwai Y., Kohno K.
Natural Compounds with Cell Growth Inhibitory Activity in Human Tumor Cell Lines
Cazal C., Choosang K., Severino V., Fernandes J., Silva M., Vieira P., Nascimento M., Almeida G., Vasconcelos M., Pakkong P., Pinto M.
RECKing MMP: Relevance of Reversion-inducing Cysteine-rich Protein with Kazal Motifs as a Prognostic Marker and Therapeutic Target for Cancer (A Review)
Nagini S.
Therapeutic Exploitation of Apoptosis and Autophagy for Glioblastoma
Kogel D., Fulda S., Mittelbronn M.
An Orally Bioavailable c-Met Kinase Inhibitor Potently Inhibits Brain Tumor Malignancy and Growth
Guessous F., Zhang Y., diPierro C., Marcinkiewicz L., Sarkaria J., Schiff D., Buchanan S., Abounader R.
Inhibitors of Cancer Stem Cells
García-Rubiño M., Lozano-López C., Campos J.
Preclinical Development of Novel Rac1-GEF Signaling Inhibitors using a Rational Design Approach in Highly Aggressive Breast Cancer Cell Lines
Cardama G., Comin M., Hornos L., Gonzalez N., Defelipe L., Turjanski A., Alonso D., Gomez D., Menna P.
Methylenedioxy- and Ethylenedioxy-Fused Indolocarbazoles: Potent Human Topoisomerase I Inhibitors and Antitumor Agents
E. Zembower D., Xie Y., Koohang A., J. Kuffel M., M. Ames M., Zhou Y., Mishra R., Aye Mar A., T. Flavin M., Xu Z.
Introduction: MMPs, ADAMs/ADAMTSs Research Products to Achieve Big Dream
Okazaki I., Nabeshima K.
The Ubiquitin+Proteasome Protein Degradation Pathway as a Therapeutic Strategy in the Treatment of Solid Tumor Malignancies
J. Driscoll J., Minter A., A. Driscoll D., K. Burris J.
Enzyme Inhibition as a Key Target for the Development of Novel Metal-Based Anti-Cancer Therapeutics
Griffith D., P. Parker J., J. Marmion C.
Discovery of Small Molecule c-Met Inhibitors: Evolution and Profiles of Clinical Candidates
Underiner T., Herbertz T., Miknyoczki S.
5-Lipoxygenase and Cyclooxygenase Inhibitory Dammarane Triterpenoid 1 from Borassus flabellifer Seed Coat Inhibits Tumor Necrosis Factor-α Secretion in LPSInduced THP-1 Human Monocytes and Induces Apoptosis in MIA PaCa-2 Pancreatic Cancer Cells
Sastry Yarla N., Azad R., Basha M., Rajack A., Kaladhar D.S., Kumar Allam B., Rao. Pragada R., Nand Singh K., Kumari K S., Pallu R., Parimi U., Bishayee A., Rao. Duddukuri G.
Erlotinib and Gefitinib for Elderly Patients with Advanced Non-small-cell Lung Cancer
Passaro A., Alesini D., Pochesci A., Cortesi E.
JAK2 Inhibitors for Myelofibrosis: Why are They Effective in Patients with and Without JAK2V617F Mutation?
P. S. Santos F., Verstovsek S.
Melanoma and Epigenetic Treatment: Past and Future
AM La Porta C.
Metal-Based Inhibitors of Protein Tyrosine Phosphatases
Lu L., Zhu M.
Latest Insights into the Anticancer Activity of Gold(III)-Dithiocarbamato Complexes
Ronconi L., Aldinucci D., Ping Dou Q., Fregona D.
Current Molecularly Targeting Therapies in NSCLC and Melanoma
Rajanna S., Rastogi I., Wojdyla L., Furo H., Kulesza A., Lin L., Sheu B., rakes M., Ivanovich M., Puri N.
The Microarray Gene Profiling Analysis of Glioblastoma Cancer Cells Reveals Genes Affected by FAK Inhibitor Y15 and Combination of Y15 and Temozolomide
Huang G., Ho B., Conroy J., Liu S., Qiang H., Golubovskaya V.
In Vitro Synergistic Interaction between DTA0100 and Radiation in Human Cancer Cell Lines
Bordon E., G. Leon L., Rios-Luci C., C. Lara P., M. Padron J.
Developing Phytoestrogens for Breast Cancer Prevention
M. Liu M., Huang Y., Wang J.
New Medical Strategies for Midgut Carcinoids
Nilsson O., Arvidsson Y., Johanson V., Forssell-Aronsson E., Ahlman H.
Small Molecules for Immunomodulation in Cancer: A Review
Iyer V.
Targeting the Fibroblast Growth Factor Receptors for the Treatment of Cancer
Lemieux S., Hadden M.
The Cytotoxic Effect of Emetine and CGP-74514A Studied with the Hollow Fiber Model and ArrayScan Assay in Neuroendocrine Tumors In Vitro
E. Larsson D., B. Hassan S., Oberg K., Granberg D.
New Targeted Therapies for Anaplastic Thyroid Cancer
Antonelli A., Fallahi P., Ulisse S., Martina Ferrari S., Minuto M., Saraceno G., Santini F., Mazzi V., D'Armiento M., Miccoli P.
Updates of mTOR Inhibitors
Zhou H., Luo Y., Huang S.
Anaplastic Lymphoma Kinase as a Therapeutic Target in Anaplastic Large Cell Lymphoma, Non-Small Cell Lung Cancer and Neuroblastoma
Cheng M., R. Ott G.
Novel Arcyriaflavin-A Derivatives as PIM Kinase Inhibitors for Treating Cancer
De S.
Marizomib, A Potent Second Generation Proteasome Inhibitor from Natural Origin
Ma L., Diao A.
FAK and Nanog Cross Talk with p53 in Cancer Stem Cells
M. Golubovskaya V.
MMPs in Ovarian Cancer as Therapeutic Targets
Karam A., Dorigo O.
Ceramidases in Hematological Malignancies: Senseless or Neglected Target?
Fabrias G., Bedia C., Casas J., Luis Abad J., Delgado A.
STAT3 as a Therapeutic Target for Glioblastoma
Liu Y., Li C., Lin J.
Focal Adhesion Kinase as a Therapeutic Target of Bortezomib
Ko B., Chang T., Liou J.
A Natural Anticancer Agent Thaspine Targets Human Topoisomerase IB
Castelli S., Katkar P., Vassallo O., Falconi M., Linder S., Desideri A.
1 - 55 of 55 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"